# PIMAVANSERIN
> **ANDA214750** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2021-04-08
## Drug
- **FDA Application Number:** ANDA214750
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIMAVANSERIN
- **Generic name:** Pimavanserin
- **Active ingredients:** PIMAVANSERIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2021-04-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214750)
---
*AI Analytics · CC0 1.0*